Drug Trial Radar · NCT01793090
EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment
Last checked: Nov 20, 2026Latest source record: Apr 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jan 2013
Primary completion
Jul 2013
Study completion Feb 2017
Sponsor
- Lead sponsor
- Bambino Gesù Hospital and Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Catholic University of the Sacred Heart
- First posted
- Feb 15, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the research is to investigate the safety and efficacy of EPI-743 treatment in patients with Cbl-C defect and related visual and neurological impairment. Primary Endpoints will be the improvement in visual function as assessed by visual acuity and eye-hand coordination and manual dexterity. Secondary Endpoints will be the improvement in neurologic function, evaluated by a battery of age-appropriated psychophysical tests, and/or in objective electrophysiological tests such as Visual Evoked potentials (VEP) and Electroretinogram (ERG) and/or the change in serum markers of redox state.
Conditions
- Methylmalonic Aciduria and Homocystinuria,Cblc Type
- Genetic Disease
- Retinopathy
Interventions
Epi-743Drug
EPI- 743 in capsule or formulation comprised of USP/NF Sesame Oil at a potency of 100 mg EPI-743/ 1 mL total volume. Mode of Administration: Oral with meal or G-Tube infusion with food.
Placebo supplementationOther
Placebo will be administered in the same formulation as the active comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Visual FunctionTime frame: Baseline, six months, twelve months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bambino Gesù Hospital and Research Institute
Rome, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.